GRCE
Grace Therapeutics, Inc.
NASDAQ: GRCE · HEALTHCARE · BIOTECHNOLOGY
$2.01
+7.49% today
Updated 2026-10-28
Market cap
$40.28M
P/E ratio
—
P/S ratio
197.75x
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Grace Therapeutics, Inc. (GRCE) Insider transactions
Net insider activity
Net buying (0 shares)
Buy transactions
0
Sell transactions
0
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|